Product Information
GGTI-2133 is a chemokine that has been shown to be a potent autophagy inducer. Autophagy is the process by which cells break down and recycle their own components in order to maintain homeostasis. GGTI-2133 has been shown to inhibit cholesterol synthesis, decrease lung damage, and induce bronchial dilation. The drug has also been shown to increase the production of geranylgeranylated proteins, which may have therapeutic potential for cancer treatment. A molecular modeling study of GGTI-2133 shows that it binds to the same binding site as statins on HMG-CoA reductase, an enzyme involved in cholesterol synthesis. This may lead to synergistic effects when taken with statins for the treatment of cardiovascular disease and diabetes mellitus type II.
Chemical properties
Technical inquiry about: 3D-SYB48014 GGTI-2133
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
